前立腺がん治療薬の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Prostate Cancer Treatment Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-00448 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、前立腺がん治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。前立腺がん治療薬の種類別市場規模（ザイティガ、ゴナックス、リュープロン、ゾラデックス、デカペプチル、エリガード、ヴァンタス、カソデックス、その他）、用途別市場規模（病院、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Johnson & Johnson、Ipsen、Astella、Dendreon、Sanofi、AstraZeneca、Bayer ・地域別グローバル市場分析 2015年-2020年 ・前立腺がん治療薬の北米市場（アメリカ、カナダ、メキシコ） ・前立腺がん治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・前立腺がん治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・前立腺がん治療薬の南米市場（ブラジル、アルゼンチン） ・前立腺がん治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ザイティガ、ゴナックス、リュープロン、ゾラデックス、デカペプチル、エリガード、ヴァンタス、カソデックス、その他 ・用途別分析：病院、外来手術センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Prostate Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Prostate Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Prostate Cancer Treatment Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Prostate Cancer Treatment Drugs market has been segmented into:
Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Casodex
Others

By Application, Prostate Cancer Treatment Drugs has been segmented into:
Hospitals
Ambulatory Surgical Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Treatment Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Treatment Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Treatment Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Treatment Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Prostate Cancer Treatment Drugs Market Share Analysis
Prostate Cancer Treatment Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Treatment Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Treatment Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Prostate Cancer Treatment Drugs are:
Johnson & Johnson
Ipsen
Astella
Dendreon
Sanofi
AstraZeneca
Bayer

レポート目次

---

Table of Contents

1 Prostate Cancer Treatment Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Treatment Drugs
1.2 Classification of Prostate Cancer Treatment Drugs by Type
1.2.1 Global Prostate Cancer Treatment Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Type in 2019
1.2.3 Zytiga
1.2.4 Gonax
1.2.5 Lupron
1.2.6 Zoladex
1.2.7 Decapeptyl
1.2.8 Eligard
1.2.9 Vantas
1.2.10 Casodex
1.2.11 Others
1.3 Global Prostate Cancer Treatment Drugs Market by Application
1.3.1 Overview: Global Prostate Cancer Treatment Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Global Prostate Cancer Treatment Drugs Market by Regions
1.4.1 Global Prostate Cancer Treatment Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Prostate Cancer Treatment Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Prostate Cancer Treatment Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Treatment Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Treatment Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Prostate Cancer Treatment Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Treatment Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ipsen
2.2.1 Ipsen Details
2.2.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ipsen SWOT Analysis
2.2.4 Ipsen Product and Services
2.2.5 Ipsen Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astella
2.3.1 Astella Details
2.3.2 Astella Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astella SWOT Analysis
2.3.4 Astella Product and Services
2.3.5 Astella Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Dendreon
2.4.1 Dendreon Details
2.4.2 Dendreon Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Dendreon SWOT Analysis
2.4.4 Dendreon Product and Services
2.4.5 Dendreon Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer SWOT Analysis
2.7.4 Bayer Product and Services
2.7.5 Bayer Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Prostate Cancer Treatment Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Treatment Drugs Players Market Share
3.2.2 Top 10 Prostate Cancer Treatment Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Regions
4.2 North America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
5 North America Prostate Cancer Treatment Drugs Revenue by Countries
5.1 North America Prostate Cancer Treatment Drugs Revenue by Countries (2015-2020)
5.2 USA Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6 Europe Prostate Cancer Treatment Drugs Revenue by Countries
6.1 Europe Prostate Cancer Treatment Drugs Revenue by Countries (2015-2020)
6.2 Germany Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6.4 France Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Prostate Cancer Treatment Drugs Revenue by Countries
7.1 Asia-Pacific Prostate Cancer Treatment Drugs Revenue by Countries (2015-2020)
7.2 China Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7.5 India Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
8 South America Prostate Cancer Treatment Drugs Revenue by Countries
8.1 South America Prostate Cancer Treatment Drugs Revenue by Countries (2015-2020)
8.2 Brazil Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Prostate Cancer Treatment Drugs by Countries
9.1 Middle East & Africa Prostate Cancer Treatment Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Prostate Cancer Treatment Drugs Market Forecast by Type (2019-2024)
10.3 Zytiga Revenue Growth Rate (2015-2025)
10.4 Gonax Revenue Growth Rate (2015-2025)
10.5 Lupron Revenue Growth Rate (2015-2025)
10.6 Zoladex Revenue Growth Rate (2015-2025)
10.7 Decapeptyl Revenue Growth Rate (2015-2025)
10.8 Eligard Revenue Growth Rate (2015-2025)
10.9 Vantas Revenue Growth Rate (2015-2025)
10.10 Casodex Revenue Growth Rate (2015-2025)
10.11 Others Revenue Growth Rate (2015-2025)
11 Global Prostate Cancer Treatment Drugs Market Segment by Application
11.1 Global Prostate Cancer Treatment Drugs Revenue Market Share by Application (2015-2020)
11.2 Prostate Cancer Treatment Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Prostate Cancer Treatment Drugs Market Size Forecast (2021-2025)
12.1 Global Prostate Cancer Treatment Drugs Market Size Forecast (2021-2025)
12.2 Global Prostate Cancer Treatment Drugs Market Forecast by Regions (2021-2025)
12.3 North America Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
12.6 South America Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Prostate Cancer Treatment Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Cancer Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Cancer Treatment Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Prostate Cancer Treatment Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Johnson & Johnson Corporate Information, Location and Competitors
Table 6. Johnson & Johnson Prostate Cancer Treatment Drugs Major Business
Table 7. Johnson & Johnson Prostate Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Johnson & Johnson SWOT Analysis
Table 9. Johnson & Johnson Prostate Cancer Treatment Drugs Product and Solutions
Table 10. Johnson & Johnson Prostate Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Ipsen Corporate Information, Location and Competitors
Table 12. Ipsen Prostate Cancer Treatment Drugs Major Business
Table 13. Ipsen Prostate Cancer Treatment Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Ipsen SWOT Analysis
Table 15. Ipsen Prostate Cancer Treatment Drugs Product and Solutions
Table 16. Ipsen Prostate Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astella Corporate Information, Location and Competitors
Table 18. Astella Prostate Cancer Treatment Drugs Major Business
Table 19. Astella Prostate Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Astella SWOT Analysis
Table 21. Astella Prostate Cancer Treatment Drugs Product and Solutions
Table 22. Astella Prostate Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Dendreon Corporate Information, Location and Competitors
Table 24. Dendreon Prostate Cancer Treatment Drugs Major Business
Table 25. Dendreon Prostate Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Dendreon SWOT Analysis
Table 27. Dendreon Prostate Cancer Treatment Drugs Product and Solutions
Table 28. Dendreon Prostate Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sanofi Corporate Information, Location and Competitors
Table 30. Sanofi Prostate Cancer Treatment Drugs Major Business
Table 31. Sanofi Prostate Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Sanofi SWOT Analysis
Table 33. Sanofi Prostate Cancer Treatment Drugs Product and Solutions
Table 34. Sanofi Prostate Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AstraZeneca Corporate Information, Location and Competitors
Table 36. AstraZeneca Prostate Cancer Treatment Drugs Major Business
Table 37. AstraZeneca Prostate Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 38. AstraZeneca SWOT Analysis
Table 39. AstraZeneca Prostate Cancer Treatment Drugs Product and Solutions
Table 40. AstraZeneca Prostate Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer Corporate Information, Location and Competitors
Table 42. Bayer Prostate Cancer Treatment Drugs Major Business
Table 43. Bayer Prostate Cancer Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Bayer SWOT Analysis
Table 45. Bayer Prostate Cancer Treatment Drugs Product and Solutions
Table 46. Bayer Prostate Cancer Treatment Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Prostate Cancer Treatment Drugs Revenue (Million USD) by Players (2015-2020)
Table 48. Global Prostate Cancer Treatment Drugs Revenue Share by Players (2015-2020)
Table 49. Global Prostate Cancer Treatment Drugs Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions (2015-2020)
Table 51. North America Prostate Cancer Treatment Drugs Revenue by Countries (2015-2020)
Table 52. North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 53. Europe Prostate Cancer Treatment Drugs Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Prostate Cancer Treatment Drugs Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Prostate Cancer Treatment Drugs Revenue by Countries (2015-2020)
Table 56. South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Prostate Cancer Treatment Drugs Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Global Prostate Cancer Treatment Drugs Revenue (Million USD) by Type (2015-2020)
Table 60. Global Prostate Cancer Treatment Drugs Revenue Share by Type (2015-2020)
Table 61. Global Prostate Cancer Treatment Drugs Revenue Forecast by Type (2021-2025)
Table 62. Global Prostate Cancer Treatment Drugs Revenue by Application (2015-2020)
Table 63. Global Prostate Cancer Treatment Drugs Revenue Share by Application (2015-2020)
Table 64. Global Prostate Cancer Treatment Drugs Revenue Forecast by Application (2021-2025)
Table 65. Global Prostate Cancer Treatment Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Prostate Cancer Treatment Drugs Picture
Figure 2. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type in 2019
Figure 3. Zytiga Picture
Figure 4. Gonax Picture
Figure 5. Lupron Picture
Figure 6. Zoladex Picture
Figure 7. Decapeptyl Picture
Figure 8. Eligard Picture
Figure 9. Vantas Picture
Figure 10. Casodex Picture
Figure 11. Others Picture
Figure 12. Prostate Cancer Treatment Drugs Revenue Market Share by Application in 2019
Figure 13. Hospitals Picture
Figure 14. Ambulatory Surgical Centers Picture
Figure 15. Global Prostate Cancer Treatment Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Prostate Cancer Treatment Drugs Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Prostate Cancer Treatment Drugs Revenue Market Share in 2019
Figure 24. Global Top 10 Players Prostate Cancer Treatment Drugs Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions (2015-2020)
Figure 28. Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions in 2018
Figure 29. North America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Europe Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 32. South America Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 34. North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 35. North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 36. USA Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Canada Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 41. Germany Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 42. UK Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 43. France Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Russia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Italy Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 48. China Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Japan Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Korea Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 51. India Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 53. South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 55. Brazil Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 60. UAE Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Prostate Cancer Treatment Drugs Revenue and Growth Rate (2015-2020)
Figure 63. Global Prostate Cancer Treatment Drugs Revenue Share by Type (2015-2020)
Figure 64. Global Prostate Cancer Treatment Drugs Revenue Share by Type in 2019
Figure 65. Global Prostate Cancer Treatment Drugs Market Share Forecast by Type (2021-2025)
Figure 66. Global Zytiga Revenue Growth Rate (2015-2020)
Figure 67. Global Gonax Revenue Growth Rate (2015-2020)
Figure 68. Global Lupron Revenue Growth Rate (2015-2020)
Figure 69. Global Zoladex Revenue Growth Rate (2015-2020)
Figure 70. Global Decapeptyl Revenue Growth Rate (2015-2020)
Figure 71. Global Eligard Revenue Growth Rate (2015-2020)
Figure 72. Global Vantas Revenue Growth Rate (2015-2020)
Figure 73. Global Casodex Revenue Growth Rate (2015-2020)
Figure 74. Global Others Revenue Growth Rate (2015-2020)
Figure 75. Global Prostate Cancer Treatment Drugs Revenue Share by Application (2015-2020)
Figure 76. Global Prostate Cancer Treatment Drugs Revenue Share by Application in 2019
Figure 77. Global Prostate Cancer Treatment Drugs Market Share Forecast by Application (2021-2025)
Figure 78. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 79. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 80. Global Prostate Cancer Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Prostate Cancer Treatment Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Prostate Cancer Treatment Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 84. Europe Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 86. South America Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel

---